These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression. Becker OM, Dhanoa DS, Marantz Y, Chen D, Shacham S, Cheruku S, Heifetz A, Mohanty P, Fichman M, Sharadendu A, Nudelman R, Kauffman M, Noiman S. J Med Chem; 2006 Jun 01; 49(11):3116-35. PubMed ID: 16722631 [Abstract] [Full Text] [Related]
47. 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potency. Borthwick AD, Davies DE, Exall AM, Hatley RJ, Hughes JA, Irving WR, Livermore DG, Sollis SL, Nerozzi F, Valko KL, Allen MJ, Perren M, Shabbir SS, Woollard PM, Price MA. J Med Chem; 2006 Jul 13; 49(14):4159-70. PubMed ID: 16821776 [Abstract] [Full Text] [Related]
48. Arylpiperazines with N-acylated amino acids as 5-HT1A receptor ligands. Zajdel P, Subra G, Bojarski AJ, Duszyńska B, Pawłowski M, Martinez J. Bioorg Med Chem Lett; 2006 Jul 01; 16(13):3406-10. PubMed ID: 16677812 [Abstract] [Full Text] [Related]
49. Positive and negative modulation of group I metabotropic glutamate receptors. Vanejevs M, Jatzke C, Renner S, Müller S, Hechenberger M, Bauer T, Klochkova A, Pyatkin I, Kazyulkin D, Aksenova E, Shulepin S, Timonina O, Haasis A, Gutcaits A, Parsons CG, Kauss V, Weil T. J Med Chem; 2008 Feb 14; 51(3):634-47. PubMed ID: 18173231 [Abstract] [Full Text] [Related]
50. Sulfonamides with the N-alkyl-N'-dialkylguanidine moiety as 5-HT7 receptor ligands. Zajdel P, Subra G, Verdie P, Gabzdyl E, Bojarski AJ, Duszyńska B, Martinez J, Pawłowski M. Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4827-31. PubMed ID: 19560916 [Abstract] [Full Text] [Related]
53. (2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a potent and selective 5-HT(1A) receptor agonist. Franchini S, Tait A, Prandi A, Sorbi C, Gallesi R, Buccioni M, Marucci G, De Stefani C, Cilia A, Brasili L. ChemMedChem; 2009 Feb 15; 4(2):196-203. PubMed ID: 19101959 [Abstract] [Full Text] [Related]
55. Synthesis of new (benzimidazolyl)piperazines with affinity for the 5-HT1A receptor via Pd(0) amination of bromobenzimidazoles. López-Rodríguez ML, Viso A, Benhamú B, Rominguera JL, Murcia M. Bioorg Med Chem Lett; 1999 Aug 16; 9(16):2339-42. PubMed ID: 10476865 [Abstract] [Full Text] [Related]
57. N-Propylnoraporphin-11-O-yl carboxylic esters as potent dopamine D(2) and serotonin 5-HT(1A) receptor dual ligands. Liu Z, Chen X, Sun P, Yu L, Zhen X, Zhang A. Bioorg Med Chem; 2008 Sep 15; 16(18):8335-8. PubMed ID: 18783955 [Abstract] [Full Text] [Related]
58. Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model. Muñoz A, Carlsson T, Tronci E, Kirik D, Björklund A, Carta M. Exp Neurol; 2009 Sep 15; 219(1):298-307. PubMed ID: 19500572 [Abstract] [Full Text] [Related]
59. Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation. Badarau E, Suzenet F, Bojarski AJ, Fînaru AL, Guillaumet G. Bioorg Med Chem Lett; 2009 Mar 15; 19(6):1600-3. PubMed ID: 19237285 [Abstract] [Full Text] [Related]
60. Synthesis and receptor binding of new thieno[2,3-d]-pyrimidines as selective ligands of 5-HT(3) receptors. Modica MN, Romeo G, Salerno L, Pittalà V, Siracusa MA, Mereghetti I, Cagnotto A, Mennini T, Gáspár R, Gál A, Falkay G, Palkó M, Maksay G, Fülöp F. Arch Pharm (Weinheim); 2008 Jun 15; 341(6):333-43. PubMed ID: 18535994 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]